OPRX (OptimizeRx) Multiplikator Forward P/S

Logo perusahaan publik OptimizeRx Inc. (OPRX)

The scaling of the marketing platform and long-term agreements with pharmaceutical behemoths create a sustainable profit stream for OptimizeRx Corporation (OPRX). The forward P/S indicator visualizes this trend, with the metric holding around 0.50. The business model relies on B2B advertising within electronic health records, while the high margins of digital services guarantee excess liquidity with low development costs.

OPRX OptimizeRx Corp: Rega forward marang dodolan ing interval 04.07.2022 - 13.11.2026

Rincian metrik komprehensif lan analitis OptimizeRx Inc. (OPRX)

- rega saham lan target rega konsensus:
Analisis kabeh metrik perusahaan:OPRX (OptimizeRx)
Produk sing diprodhuksi OptimizeRx Inc.

To select high-quality assets, it is essential for an investor to compare a company's market value with its projected revenue stream to determine the degree of business overvaluation. This calculation, reflecting the ratio of market capitalization to expected earnings, allows for an assessment of the effectiveness of OptimizeRx Corporation (OPRX) digitalization of marketing at points of care, where the forward P/S ratio trend serves as an indicator of the sustainability of its cloud product expansion.

Analisis pesaing

Veeva - Multiplikator forward rega marang pendapatan|DOCS (Doximity Inc) - Rega mangsa ngarep marang pendapatan|HealthEquity Corp - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Waystar Corp|CorVel Corporation (CRVL) - Rasio rega marang prakiraan pendapatan|priviahealth.com - Rega forward marang dodolan|Multiplikator forward rega marang pendapatan HURN|Kapitalisasi marang prakiraan pendapatan CERT (Certara Inc)|Multiplikator forward rega marang pendapatan OMCL (Omnicell Corp)|GDRX (GoodRx Gold) - Rega forward marang dodolan|Multiplikator Forward P/S SDGR (Schrodinger, Inc.)|PHR - Multiplikator forward rega marang pendapatan|OMDA - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Evolent Health Inc|HealthStream Corp (HSTM) - Rasio rega marang prakiraan pendapatan|Definitive Corp - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Consensus Cloud Solutions|agilonhealth.com - Rega mangsa ngarep marang pendapatan|Rasio rega marang prakiraan pendapatan Absci Corporation (ABSI)|SY - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Rasio rega marang prakiraan pendapatan National Research Corporation NRC|Rega forward marang dodolan SPOK|TruBridge, Inc. - Multiplikator Forward P/S|SLP - Multiplikator Forward P/S|SOPH (sophiagenetics.com) - Multiplikator forward rega marang pendapatan|HCAT: Rasio rega marang pendapatan sing dikarepake|CCLD (CareCloud Inc.) - Multiplikator Forward P/S|Research Solutions Inc. (RSSS) - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan DLH Holdings Corp. (DLHC)|ONMD - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Rasio rega marang prakiraan pendapatan Scienture SCNX|HCTI: Kapitalisasi marang prakiraan pendapatan|ISPC - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Bullfrog AI Holdings|SCWorx Corp. (WORX) - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan MSPR (msprecovery.com)|Rasio rega marang prakiraan pendapatan iCoreConnect, Inc.|MEDS: Rega forward marang dodolan|Multiplikator forward rega marang pendapatan ORGS (Orgenesis Corp)|r1rcm.com - Kapitalisasi marang prakiraan pendapatan|Multiplikator Forward P/S SHCR (Sharecare, Inc.)|Rasio kapitalisasi marang dodolan sing dikarepake streamlinehealth.net (STRM)|SYRA: Multiplikator forward rega marang pendapatan|Apollo Medical Holdings - Rasio rega marang pendapatan sing dikarepake|MODN (Model N Corp) - Multiplikator forward rega marang pendapatan|NextGen Healthcare Corp - Rega forward marang dodolan